Introduction
============

Crimean-Congo Hemorrhagic Fever (CCHF) is a serious disease occurring in case of infection by tick-borne virus (*Nairovirus*) genus from Bunyaviridae family ([@B10]). It begins with fever, severe headache, nausea, weakness, vomiting and progresses with bleeding in different parts of the body. "The bleeding findings emerge as subcutaneous bleeding, nasal bleeding, gingival bleeding and visceral bleeding" ([@B1]). Mononuclear phagocytic cells, hepatocytes and endothelial cells are known as main target of CCHF virus ([@B33], [@B8]).

CCHF cases have been reported from more than 30 countries of Asia, South-Eastern Europe and Africa until now ([@B15]). In Turkey, annually more than 1,000 human CCHF cases are reported ([@B21]).

Like sepsis, endothelial damage plays an important role in the pathogenesis of CCHF. Endothelium may be indirectly targeted by virus mediated host derived soluble factors or directly by viral factors ([@B27]). Hypoxia inducible factor (HIF-1α) is an oxygen sensitive transcription factor facilitating oxygen distribution and cellular adaptation to oxygen deprivation. HIF-1α activates transcription of genes, which encode angiogenic growth factors, including vascular endothelial growth factor (VEGF), angiopoietin 1 (ANGPT1), (ANGPT2), placental growth factor (PGF) and platelet-derived growth factor B (PDGFB), playing a critical role in angiogenesis. HIF-1α regulates expression of certain genes related with erythropoiesis, energy metabolism, angiogenesis, cell proliferation and apoptosis ([@B11], [@B26], [@B22]).

Vascular Endothelial Growth Factor (VEGF-A), a member of platelet-derived growth factors super family is specific for the endothelial cells and has important effects. Blood vessel formation is regulated mainly by vascular endothelial growth factor (VEGF-A) in health and disease. Human VEGF gene family consists of five members of VEGF A-E, among which VEGF-A is also commonly referred to as VEGF ([@B11]).

VEGF-A was also known as vascular permeability factor (VPF) due to its substantial effect on increasing of vascular permeability, resulting in a leakage out of blood vessels. One of the main aberrations in pathogenesis of CCHF is vascular dysfunction resulting in leakage driven hemorrhagic manifestations ([@B6], [@B14], [@B9]).

In this study, we aimed to demonstrate whether VEGF-A and HIF-1α was correlated with pathogenesis of sepsis in serum samples obtained from CCHF patients and control group.

Materials and Methods
=====================

Study design
------------

Thirty patients diagnosed with CCHF in Department of Pediatrics, Faculty of Medicine, Cumhuriyet University, from 2010 to 2011 and 30 healthy controls were enrolled in the study. All of the patients with CCHF used to live in the same endemic region (Sivas and neighbor's cities) which showed high prevalence in CCHF. Blood samples collected from the hospitalized patients with presumed diagnosis of CCHF were sent to Refik Saydam Hifzisihha Center, Virology Laboratory. Thirty patients having positive CCHFV RNA with Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) and/or positive CCHFV-specific IgM with ELISA were included in the study. Thirty age and sex matched healthy individuals who had not any infectious or metabolic diseases were enrolled as the controls.

This study was approved by the Local Ethics Committee of Cumhuriyet University, Faculty of Medicine.

Measurement of HIF-1α and VEGF-A levels
---------------------------------------

Blood samples of 5 ml were collected from patient and control groups. The samples were centrifuged at 3000 rpm for 5 min and obtained serums were portioned and kept at −80 °C until the analysis time. Then these samples were cooled to the room temperature at the same time and HIF-1α and VEGF-A levels were measured through ELISA method. Human/Mouse Total HIF-1 alpha Cell-Based ELISA (R and D Systems, Inc.) and VEGF-A Human (BioVendor) kits were used to measure the levels of HIF-1α and VEGF-A. MicroELISA (sandwich) method was performed using full automatic TRITURUS device.

Statistical analysis
--------------------

All statistical analyses were conducted with IBM SPSS Statistics for Windows, Version 20.0 (Chicago, IL, USA) computer program. Descriptive statistics were expressed as arithmetic mean (min-max). Mann--Whitney U test was performed to determine the significance of independent continuous variables. For bivariate correlation analysis, Pearson's or Spearman's test was used. In evaluation of the categorical data, Chi-square test was used in the statistical analyses. P\< 0.05 values were considered as statistically significant for all the tests.

Results
=======

Demographic features and laboratory findings of the controls and patient groups are given in [Table 1](#T1){ref-type="table"}. Mean age was found as 11.30±4.41 in the patients and 10.40±4.49 in the controls. Nineteen of the patients were male (63.3%) and 11 were female (36.7%), whereas 20 (66.7%) of the controls were male and 10 (33.3%) were female. The differences between the controls and patient groups in terms of age and gender were not significant.

###### 

Comparison of demographic and laboratory findings of the patients and controls

  **Variable**                             **Control (n=30)**   **CCHF (n=30**)     **P**
  ---------------------------------------- -------------------- ------------------- -------------
  **Age (mean±SD)**                        10.40±4.49           11.30±4.41          0.05
  **Age range**                            2--17                2--17               0.05
  **Male (%)**                             20 (66.7%)           19 (63.3%)          0.05
  **Female (%)**                           20 (66.7%)           19 (63.3%)          0.05
  **ALT (IU/L)**                           35 (12--48)          83 (28--335)        **\<0.001**
  **AST (IU/L)**                           38 (11--54)          171 (26--357)       **\<0.001**
  **CK (IU/L)**                            107 (68--172)        899 (140--1235)     **\<0.001**
  **Prothrombin time (s)**                 14.4 (9.6--14.0)     15.9 (9.6--20.1)    \>0.05
  **aPTT (s)**                             34.7 (13.5--45.7)    42.4 (23.8--55.1)   **0.022**
  **INR**                                  1.2 (0.8--2.2)       1.3 (0.9--2.4)      \>0.05
  **WBC (×10^9^ cells/L)**                 5.7 (3.5--7.0)       3.17 (1.2--9.0)     **\<0.05**
  **Hemoglobin (g/dL)**                    14.2 (8.3--15.8)     13.6 (11.8--15.8)   \>0.05
  **Thrombocyte count (×10^3^ cells/L)**   176 (69--214)        110 (38--152)       **\<0.001**

**ALT:** Alanine aminotransferase

**AST:** Aspartate aminotransferase

**CK:** Creatine kinase

**aPTT:** activated partial thromboplastin time

**INR:** International normalized ratio

**WBC:** White blood cell

A statistically significant increase was observed in the levels of HIF-1α and VEGF in the patients compared to control groups (P\< 0.05, [Table 2](#T2){ref-type="table"}). A significant positive correlation was found between the levels of HIF-1α and VEGF-A in patient group (P\< 0.01, [Table 2](#T2){ref-type="table"}). A positive correlation was found among the levels of AST and CK from biochemical parameters and VEGF and HIF-1α (P\< 0.05), while this was not significant in ALT (P= 0.086, [Table 3](#T3){ref-type="table"}).

###### 

Serum levels of VEGF-A and HIF-1α in the patient and control groups

                       **Patients**   **Control**    **P**
  -------------------- -------------- -------------- -----------
  **VEGF-A (pg/ml)**   312.66±87.31   150.70±78.48   **0.001**
  **HIF-1α (pg/ml)**   195.93±63.49   68.20±36.11    **0.001**

###### 

HIF-1α and VEGF-A correlation between biochemical parameters in patients with CCHF

  **Variable**   **HIF-1α**   **VEGF-A**           
  -------------- ------------ ------------ ------- -----------
  **ALT**        0.181        0.086        0.162   0.103
  **AST**        0.256        **0.020**    0.266   **0.022**
  **CK**         0.214        **0.012**    0.292   **0.048**
  **VEGF-A**     0.969        **\<0.01**   \-      \-

**ALT:** Alanine aminotransferase

**AST**: Aspartate aminotransferase

**CK**: Creatine kinase

The levels of ALT, AST and CK were statistically significantly higher in CCHF patients than in the control group (P\< 0.001). There was a significant increase in the levels of aPTT in coagulation tests compared to controls (P=0.022), increase in the prothrombin time and INR was not statistically significant (P\> 0.05 [Table 1](#T1){ref-type="table"}). WBC (P\< 0.05) and thrombocyte counts (P\< 0.001) were statistically lower in the patients than in the control group, while no significant difference was observed in the amount of hemoglobin.

Discussion
==========

We aimed to demonstrate whether HIF-1α and VEGF, related to sepsis and viral infection, were correlated with pathogenesis of CCHF disease.

Despite numerous studies conducted about CCHF, pathogenesis of the disease is not fully understood. There was a relationship between sepsis and viral infection, and HIF-1α and VEGF ([@B16]). In infected humans by the CCHFV, damaging of endothelial cells and vascular leakage may be a direct result of an immune mediated indirect effect ([@B27]).

A common characteristic of viral hemorrhagic fevers is viruses to enter macrophages and dendritic cells, making a cytopathic effect. VEGF produced by monocytes and endothelial cells is known to play an important role in breakdown of coagulation, leukocyte adhesion, angiogenesis and increased vascular permeability ([@B4], [@B13]). It is known as a deteriorated coagulation, leukocyte adhesion, angiogenesis and increased vascular permeability in CCHF patients ([@B3]).

Clinical symptoms of CCHF are similar to sepsis and endothelial structure of vessels is retrograded ([@B7]). The correlation of sepsis and viral infection with HIF-1α and VEGF-A was shown ([@B19], [@B36]).

At hypoxic conditions, hypoxia-inducible factor (HIF) regulates expression of certain genes. In *in vivo* and *in vitro* studies, oxygen tension affects virus production either up regulating or down regulating viral replication depending on virus type and method used for to study viral replication. Viral replication is modulated mainly by HIF-1α in normal and hypoxic conditions ([@B23]).

HIF-1α is known to activate transcription of the genes including VEGF and other angiogenic growth factors and plays a critical role in the development of angiogenesis in hypoxic conditions ([@B22]). HIF-1α mRNA expression was suppressed and conversely associated with disease severity in sepsis ([@B28]). HIF-1α expression was statistically significantly higher in the shock patients compared to the controls and the reasons of shock were sepsis (78%), hemorrhage (18%), and cardiac dysfunction (4%) ([@B30]).

In sepsis, microvascular permeability closely associates with the increased plasma VEGF concentration ([@B25]). ROS--HIF-1α--VEGF pathway is partly responsible for hypoxia-induced permeability ([@B16]). The levels of VEGF increased in sepsis, and this increase correlated with severity of the disease and mortality ([@B32], [@B34], [@B18]).

Inhibition of VEGF signaling contributes the development of sepsis-induced organ dysfunction via blocking endothelial survival and increasing apoptosis. Furthermore, in pathological situations like sepsis and cancer, VEGF participates to mobilizing of endothelial progenitor cells ([@B17]).

The main target of sepsis-induced events is generally endothelium, so ability to ameliorate damaged endothelium is one of the main determiners of clinical outcome in septic patients. The angiogenic factors and their soluble receptors have a dual role and seem to play both beneficial and harmful effects during sepsis development and therapy. While normal levels of VEGF is required for protection of endothelial function, both extremely high or low levels of VEGF have disruptive effect on endothelial barrier ([@B35]).

In our study, a strong correlation was seen between the levels of HIF-1α and VEGF-A in CCHF patients ([Table 3](#T3){ref-type="table"}). Besides, a positive correlation was found between HIF-1α and VEGF-A, suggesting that angiogenesis could be triggered and, pathogenesis of the disease could be influenced. Accordingly, we recommend that comprehensive studies related to angiogenesis should be conducted in CCHF patients.

Despite the absence of studies that investigated HIF-1α levels in patients with CCHF in the literature, the studies that evaluating VEGF levels have increased in recent years. All of the studies that investigate serum levels of VEGF have been conducted with Turkish CCHF patients. Serum levels of VEGF was statistically higher in the adult patients having CCHF compared to the controls ([@B2]), and in another study, levels of VEGF was found statistically higher in fatal CCHF patients compared to the non-fatal patients ([@B24]). In contrast to these findings, level of VEGF was significantly decreased in CCHF patients ([@B3]). Our study was not consistent with the study by Bodur et al. while it was consistent with the other two studies.

In studies conducted with other hemorrhagic fevers such as dengue hemorrhagic fever (DHF) (Tseng et al. 2000, [@B29], [@B12], [@B5]) and hemorrhagic fever with renal syndrome (HFRS) ([@B20]), also VEGF level was statistically significantly higher in patient groups. Consequently, all of these studies indicate that VEGF regulates vascular permeability and VEGF is a good marker of the severity of the infection by viral diseases such as CCHF and DHF.

Our study has some limitations. First, we could not linked the levels of HIF-1α and VEGF-A together with disease severity. Second, HIF-1α and VEGF-A serum levels were not compared between patients with survival and non-survival. Lastly, we did not evaluate the levels of VEGF-A and HIF-1α in another viral disease -especially the other hemorrhagic fevers- or patients with sepsis.

Increased levels of the HIF-1α which is the main transcriptional factor of the regulation of oxygen homeostasis and VEGF-A which has a crucial role in the regulation of angiogenesis and vascular permeability suggested that these parameters might contribute to the development of vascular endothelial damage. Nevertheless, because of the insufficient information about molecular mechanism on pathogenesis of CCHF, our results indicate that VEGF and HIF-1α should be one of the markers need to be focused on the elucidation on the pathogenesis of CCHF disease.

Conclusion
==========

Significant higher levels of HIF-1α and VEGF-A in the CCHF patients than in controls, suggested that HIF-1α and VEGF-A expression might be effective on the pathogenesis of CCHF patients, especially on the occurrence of endothelial damage and disruption of coagulation. Combined use of HIF-1α inhibitors with antiviral agents may be useful for the treatment of CCHF patients. Further comprehensive studies on this issue are recommended.
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